|
Mar 11
|
Update: Viking Therapeutics Shares Fall After Manufacturing Deal With CordenPharma
|
|
Mar 11
|
H.C. Wainwright says Novo results support Viking obesity potential
|
|
Mar 11
|
Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
|
|
Mar 11
|
Viking inks CordenPharma deal to boost obesity drug supply
|
|
Mar 11
|
Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735
|
|
Feb 28
|
1 Biotech Stock to Buy in 2025, and 1 to Avoid
|
|
Feb 28
|
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
|
|
Feb 26
|
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory
|
|
Feb 26
|
Is Viking Therapeutics a Buy Right Now?
|
|
Feb 25
|
Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect
|
|
Feb 24
|
Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now
|
|
Feb 24
|
Should You Buy VKTX Stock Amid Renewed M&A Speculations?
|
|
Feb 24
|
Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
|
|
Feb 22
|
Why Viking Therapeutics Inc. (VKTX) Surged On Friday?
|
|
Feb 20
|
Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday?
|
|
Feb 5
|
Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers
|
|
Feb 5
|
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
|
|
Feb 5
|
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
|
|
Feb 4
|
Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?
|
|
Feb 2
|
Jim Cramer’s Take on Viking Therapeutics (VKTX): “Sell Viking Therapeutics and Roll it into Viking Holdings”
|